Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

5th RNA Editing Summit

Evvnt Promotion / evvnt
Archivio
-
18.06.2024 - 20.06.2024  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temi della conferenza
Welcome to the 5th RNA Editing Summit
Pioneering RNA Editing Drugs Towards Clinical Realities
Despite remarkable advancements, such as Wave Life Sciences pioneering the first clinical candidate and significant investments like Ascidian Therapeutics securing $40 million for their RNA editing pipeline, challenges persist in optimizing delivery and ensuring treatment longevity for new RNA editing therapies.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2221213-3?pid=4832

Speakers: Andrew Fraley, Chief Technology Officer, Entrepreneur In Residence, Judo Bio, Atlas Venture, C. Anthony Altar, President and Chief Operating Officer, Splice Therapeutics, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2221213-2?pid=4832
Ms. Isabella Hunter
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developer - Conf. Only: USD 2999.00, Drug Developer - Conf. + Focus Day: USD 4197.00, Academic - Conf. Only: USD 2599.00, Academic - Conf. + Focus Day: USD 3597.00, Vendor - Conf. Only: USD 3699.00, Vendor - Conf. + Focus Day: USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Charité International AcademyCenter of ExcellenceAnästhesie in Entwicklungsländern e. V.Österreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationEuropean Health Forum GasteinHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und Medizin